Global Tissue Engineering and Regeneration Technologies and Markets Research Report 2016-2021

Dublin, April 10, 2017 -- Research and Markets has announced the addition of the "Tissue Engineering and Regeneration: Technologies and Global Markets" report to their offering.

The global market for tissue engineering and regeneration is expected to reach $60.8 billion by 2021 from $13.6 billion in 2016, rising at a compound annual growth rate (CAGR) of 34.9% from 2016 through 2021.

This report covers all the revenues earned by the regeneration therapies. These therapies are extensively used to replace and regenerate the cells, genes and tissues in a patient's body. The report considers revenue generated by the products, as well as services in the regenerative medicine market. The services include the tools, along with the cell and gene bank charges, where the cells and tissues are stored and treated properly pre- and post-experimentation and treatment. The report also covers the revenues earned by small molecules and biologics (drugs) that speed up the regeneration process. Other drug therapy revenues (e.g., painkillers, analgesics) that can be used along with regenerative therapy are not included in the report, as they do not contribute to cell or tissue regeneration. The report covers all the existing applications of the regenerative medicine therapy.

The global tissue engineering and regeneration market is primarily segmented by components, materials, applications and region. The tissue engineering and regenerative medicine component market is categorized into therapeutic products, tools, banks and services. These therapeutic products are further segmented into cell therapy, gene therapy, tissue engineering, and small molecules and biologics based on product type.

The therapeutic products are also categorized into synthetic materials, biologically derived materials, genetically engineered materials, and small molecules and biologics based on material. The report includes key technologies involved in regenerative medicine therapy. The study analyzes the clinical trials and patents conducted in respective regions. The report provides an in-depth analysis of the key companies operating in the global tissue engineering and regeneration market.

This Report Provides:

- An overview of the global market for tissue engineering and regeneration, and related technologies.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Information on the specific drivers, trends, and challenges for different segments of the market.
- Valuable insight into future trends, details on products, and information on therapies available in the field of tissue engineering.
- Analysis of the competitive environments, including new and potential markets for novel therapies and treatments.
- Profiles of major players in the industry.

Companies profiled in this report include

• Advanced Cell Technology
• Arteriocyte
• Athersys
• Bioheart
• BioMimetic
• Therapeutics
• BioTissue Technologies
• CeraPedics
• Cook Biotech
• CryoLife
• Cytograft Tissue Engineering
• Cytomedix
• Cytori Therapeutics
• Genzyme/Sanofi
• Integra LifeSciences
• International Stem Cell
• LifeCell/Kinetic Concepts
• Mesoblast.

Key Topics Covered:

1: Introduction

- Study Goals And Objectives
- Scope Of The Report
- Intended Audience
- Source Of Information And Methodology

2: Executive Summary

3: Tissue Engineering And Regeneration Market Overview

- Progress And Promises For Tissue Engineering Industry
- Nanotechnology For Tissue Regeneration
- Gene Therapies: The Future Of Tissue Engineering
- Stem Cell Technologies Boon To Tissue Engineering
- Government Regulations And Legislations
- Biopriniting Technology In Regenerative Medicine
- Porter's Five Forces Analysis Of Tissue Engineering And Regeneration Market
- Clinical Trials
- Market Dynamics

4: Tissue Engineering And Regeneration Market Analysis By Components

- Cell Therapy
- Stem Cell Therapy
- Stem Cell Sources
- Existing And Development-Stage Stem Cell Products
- Tissue Vascularization
- Cell Culturing
- Small Molecules And Biologics
- Small Molecules
- Biologics
- Tissue Engineering
- Gene Therapy

5: Tissue Engineering And Regeneration Market Analysis By Material

- Synthetic Materials
- Scaffolds: Medical Poly Lactic Acid
- Biologically Derived Materials
- Genetically Engineered Materials
- Small Molecules And Biologics

6: Tissue Engineering And Regeneration Market By Application

- Tissue Engineering And Regenerative Medicine For Cardiovascular Disorders
- Tissue Engineering And Regenerative Medicine For Oncology
- Tissue Engineering And Regenerative Medicine For Dermatology
- Tissue Engineering And Regenerative Medicine For Musculoskeletal Applications
- Tissue Engineering And Regenerative Medicine For Wound Healing
- Tissue Engineering And Regenerative Medicine For Ophthalmology
- Tissue Engineering And Regenerative Medicine For Neurology
- Tissue Engineering For Central Nervous System Diseases
- Internal Organ Regeneration

7: Tissue Engineering And Regeneration Market By Region

8: Competitive Landscape

- Approval
- Agreement, Expansion And Collaboration
- Product Launches And Patent Approvals
- Acquistions And Mergers

9: Patent Analysis

10: Company Profiles

- Arteriocyte Medical Systems Inc.
- Athersys Inc.
- Cerapedics Inc.
- Co. Don AG
- Cook Medical Inc.
- Cryolife Inc.
- Cytori Therapeutics Inc.
- Genzyme Corp.
- Kinetic Concepts Inc.
- Mesoblast Ltd.
- Nuo Therapeutics Inc. (Cytomedix Inc.)
- Ocata Therapeutics Inc. (Astellas Pharma Inc.)
- Organogenesis Inc. (Advanced Biohealing)
- Orthopeutics L.P.
- U.S. Stem Cell Inc. (Bioheart Inc.)
- Vericel Corp. (Aastrom Biosciences Inc.)
- Wright Medical Group N.V

For more information about this report visit http://www.researchandmarkets.com/research/n8jz8p/tissue

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Biomaterials